At 24 years old, Nina Luker’s life was turned upside down when she learned she had stage IV diffuse large B-cell lymphoma (DLBCL) – just three days before New York City went on lockdown due to the 2020 COVID-19 Pandemic.…
Shinning a Light on Lymphoma During Blood Cancer Awareness Month Due in large part to the Lymphoma Research Foundation’s (LRF) Advocacy Program, the month of September was designated Blood Cancer Awareness Month (BCAM) by the U.S. Congress in 2010. Blood…
As the rollout of the new COVID-19 vaccines continues, there is constant new data related to the vaccines and their effects on individuals. While most of this data is preliminary, information related to the efficacy and effect of the vaccine…
Transformed lymphoma occurs when an indolent lymphoma turns into a more aggressive one. A transformation occurs when genetic changes in the indolent lymphoma cells cause them to begin growing faster and behaving more aggressively. Lymphoma Research Foundation Grantee Raphael Eric…
There are several chemotherapy and targeted anticancer drugs approved or under investigation for the treatment of lymphoma. Unlike traditional chemotherapy that is administered intravenously (IV) in a hospital or clinic, oral therapies are administered via a pill, taken at home…
